ACTA2 Gene Aortic Aneurysm Familial Thoracic Type 6 NGS Genetic DNA Test
Comprehensive Genetic Testing for Hereditary Aortic Conditions
The ACTA2 Gene Aortic Aneurysm Familial Thoracic Type 6 NGS Genetic DNA Test represents a breakthrough in cardiovascular genetic medicine, offering precise detection of mutations associated with familial thoracic aortic aneurysms. This advanced diagnostic tool provides critical insights into inherited vascular conditions that can lead to life-threatening complications if left undetected.
What This Revolutionary Test Measures
Our state-of-the-art NGS (Next-Generation Sequencing) technology specifically targets the ACTA2 gene, which encodes alpha-actin-2, a crucial protein in vascular smooth muscle cells. The test identifies:
- Pathogenic variants in the ACTA2 gene associated with familial thoracic aortic aneurysm type 6
- Specific mutations that disrupt smooth muscle cell function
- Genetic markers indicating increased risk for aortic dissection
- Inherited patterns of vascular disease susceptibility
- Variants affecting connective tissue integrity in the aorta
Who Should Consider This Genetic Screening?
This test is particularly recommended for individuals experiencing or with family history of:
- Unexplained chest pain or back pain
- Family history of aortic aneurysms or dissections
- Sudden cardiac death in family members under age 50
- Connective tissue disorder symptoms
- Marfan-like physical features without confirmed diagnosis
- Multiple family members with cardiovascular conditions
- Unexplained vascular complications
Transformative Benefits of Early Detection
Undergoing the ACTA2 genetic test provides numerous advantages for proactive health management:
- Early Intervention Opportunities: Detect genetic predisposition before symptoms develop
- Personalized Monitoring: Create tailored surveillance plans based on genetic risk
- Family Planning Guidance: Make informed decisions about genetic inheritance
- Preventive Treatment Strategies: Implement medical therapies to slow aortic growth
- Surgical Timing Optimization: Plan elective aortic repair before emergency situations
- Family Member Screening: Identify at-risk relatives for early detection
Understanding Your Genetic Test Results
Our comprehensive genetic counseling support helps you interpret your results effectively:
- Positive Result: Indicates presence of ACTA2 mutation requiring specialized cardiovascular care and regular aortic imaging
- Negative Result: Suggests no identified ACTA2 mutation, though continued monitoring may be recommended based on family history
- Variant of Uncertain Significance: Requires additional family studies and ongoing research correlation
- Personalized Action Plan: Each result comes with specific recommendations for monitoring frequency and preventive measures
Test Pricing and Accessibility
| Test Component | Price (USD) |
|---|---|
| Discount Price | $500 |
| Regular Price | $700 |
| Test Name | ACTA2 Gene Aortic Aneurysm Familial Thoracic Type 6 NGS Genetic DNA Test |
Nationwide Testing Availability
We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, Austin, Jacksonville, Fort Worth, Columbus, San Francisco, and many more. Our network of certified genetic counselors and cardiovascular specialists ensures comprehensive care regardless of your location.
Take Control of Your Cardiovascular Health Today
Don’t wait for symptoms to develop. Early genetic detection of ACTA2 mutations can be life-saving. Our team of genetic specialists and cardiovascular experts are ready to guide you through the testing process and provide personalized recommendations based on your results.
Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic counseling session and book your ACTA2 Gene Aortic Aneurysm Test. Protect your health and your family’s future with advanced genetic insights.
Remember: Genetic testing for aortic conditions provides powerful information for proactive health management. With results available in 3-4 weeks and requiring only a simple blood sample, there’s no reason to delay this potentially life-saving screening.
